Effects of non-steroidal anti-inflammatory drug (NSAID) diclofenac exposure in mussel Mytilus galloprovincialis

Aquatic Toxicology

Volumn 148, Issue , 2014, Pages 818-831

  Gonzalez Rey, Maria ^a   Bebianno, Maria João ^a  

^a UNIVERSITY OF ALGARVE   (Portugal)

Author keywords

Antioxidant enzymes; Diclofenac; Endocrine disruption; Mytilus galloprovincialis; Neurotoxic effect

Indexed keywords

ACETYLCHOLINESTERASE; CATALASE; DICLOFENAC; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; SUPEROXIDE DISMUTASE; VITELLOGENIN;

ANTIOXIDANT; BIOACCUMULATION; BIOMARKER; BIVALVE; DRUG; ENDOCRINE DISRUPTOR; ENZYME ACTIVITY; POLLUTION EFFECT; POLLUTION EXPOSURE; TOXICITY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOCRINE FUNCTION; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; FEMALE; GILL; LIPID PEROXIDATION; MALE; MYTILUS GALLOPROVINCIALIS; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TISSUE SPECIFICITY; UPREGULATION; WATER CONTAMINATION;

EID: 84893756571     PISSN: 0166445X     EISSN: 18791514     Source Type: Journal    
DOI: 10.1016/j.aquatox.2014.01.011     Document Type: Article

References (89)

1. Ahrer W., Scherwenk E., Buchberger W. Determination of drug residues in water by the combination of liquid chromatography or capillary electrophoresis with electrospray mass spectrometry. J. Chromatogr. A 2001, 910(1):69-78.
2. Antonic J., Heath E. Determination of NSAIDs in river sediment samples. Anal. Bioanal. Chem. 2007, 387(4):1337-1342.
3. Ardaillou R., Baud L., Sraer J. Role of arachidonic acid metabolites and reactive oxygen species in glomerular immune-inflammatory process. Springer Semin. Immunopathol. 1987, 9:371-385.
4. Ashton D., Hilton M., Thomas K.V. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci. Total Environ. 2004, 333:167-184.
5. Bendz D., Paxéus N.A., Ginn T.R., Loge F.J. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden. J. Hazard. Mater. 2005, 122:195-204.
6. Besse J.-P., Garric J. Human pharmaceuticals in surface waters. Implementation of a prioritization methodology and application to the French situation. Toxicol. Lett. 2008, 176(2):104-123.
7. Blaise C., Gagné F., Pellerin J., Hansen P.D. Determination of vitellogenin-like properties in Mya arenaria hemolymph (Saguenay Fjord, Canada): a potential biomarker for endocrine disruption. Environ. Toxicol. 1999, 14:455-465.
8. Boelsterli U. Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity. Toxicol. Appl. Pharmacol. 2003, 192(3):307-322.
9. Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Bioanal. Chem. 1976, 72:248-254. 10.1016/0003-2697(76)90527-3.
10. Cajaraville M.P., Bebianno M.J., Porte C., Sarasquete C., Viarengo A. The use of biomarkers to assess the impact of pollution in coastal environments of the Iberian Peninsula: a practical approach. Sci. Total Environ. 2000, 247:295-311.
11. Canesi L., Lorusso L.C., Ciacci C., Betti M., Regoli F., Poiana G., Gallo G., Marcomini A. Effects of blood lipid lowering pharmaceuticals (bezafibrate and gemfibrozil) on immune and digestive gland functions of the bivalve mollusc, Mytilus galloprovincialis. Chemosphere 2007, 69(6):994-1002.
12. Cocco T., Di Paola M., Papa S., Lorusso M. Arachidonic acid interaction with the mitochondrial electron transport chain promotes reactive oxygen species generation. Free Radical Biol. Med. 1999, 27(1-2):51-59.
13. Cravo A., Lopes B., Serafim A., Company R., Barreira L., Gomes T., Bebianno M.J. A multibiomarker approach in Mytilus galloprovincialis to assess environmental quality. J. Environ. Monit. 2009, 11:1673-1686.
14. Cribb A.E., Leeder S., Spielberg S.P. Use of a microplate reader in an assay of glutathione reductase using 5,5-dithiobis(2-nitrobenzoic acid). Anal. Biochem. 1989, 183:195-196.
15. Delaporte M., Soudant P., Moal J., Giudicelli E., Lambert C., Séguineau C., Samain J.-F. Impact of 20:4n-6 supplementation on the fatty acid composition and hemocyte parameters of the Pacific oyster Crassostrea gigas. Lipids 2006, 41:567-576.
16. DeLorenzo M.E., Fleming J. Individual and mixture effects of selected pharmaceuticals and personal care products on the marine phytoplankton species Dunaliella tertiolecta. Arch. Environ. Contam. Toxicol. 2008, 54:203-210.
17. Ellman G.L., Courtney K.D., Andres V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-95.
18. Erdelmeier I., Gerard-Monnier D., Yadan J.C., Acudiere J. Reactions of mmethyl-2-phenlyndole with malondialdehyde and 4-hydroxyalkenals. Mechanistic aspects of the colorimetric assay of lipid peroxidation. Chem. Res. Toxicol. 1998, 11(10):1184-1194.
19. Ericson H., Thorsén G., Kumblad L. Physiological effects of diclofenac, ibuprofen and propranolol on Baltic sea blue mussels. Aquat. Toxicol. 2010, 99(2):223-231.
20. European Commission Proposal for a Directive of the European Parliament and of the Council Amending Directives 2000/60/EC and 2008/105/EC as Regards Priority Substances in the Field of Water Policy 2012, 35. European Environment Agency, Brussels.
21. European Commission Report from the Commission to the European Parliament and the Council on the Outcome of the Review of Annex X to Directive 2000/60/EC of the European Parliament and of the Council on Priority Substances in the Field of Water Policy 2012, pp. 6. European Environment Agency, Brussels.
22. Farré M.L., Ferrer I., Ginebreda A., Figueras M., Olivella L., Tirapu L., Vilanova M., Barceló D. Determination of drugs in surface water and wastewater samples by liquid chromatography-mass spectrometry: methods and preliminary results including toxicity studies with Vibrio fischeri. J. Chromatogr. A 2001, 938:187-197.
23. Fent K., Weston A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 2006, 76(2):122-159.
24. Fernández C., González-Doncel M., Pro J., Carbonell G., Tarazona J.V. Occurrence of pharmaceutically active compounds in surface waters of the henares-jarama-tajo river system (Madrid, Spain) and a potential risk characterization. Sci. Total Environ. 2010, 408:543-551.
25. Franzellitti S., Buratti S., Valbonesi P., Capuzzo A., Fabbri E. The β-blocker propranolol affects cAMP-dependent signaling and induces the stress response in Mediterranean mussels, Mytilus galloprovincialis. Aquat. Toxicol. 2011, 101(2):299-308.
26. Gagné F., Blaise C., Pellerin J., Gauthier-Clerc S. Alteration of the biochemical properties of female gonads and vitellins in the clam Mya arenaria at contaminated sites in the Saguenay Fjord. Mar. Environ. Res. 2002, 53:295-310.
27. Gagné F., André C., Cejka P., Hausler R., Fournier M. Evidence of neuroendocrine disruption in freshwater mussels exposed to municipal wastewaters. Sci. Total Environ. 2011, 409(19):3711-3718.
28. Ginebreda A., Muñoz I., de Alda M.L., Brix R., López-Doval J., Barceló D. Environmental risk assessment of pharmaceuticals in rivers: relationships between hazard indexes and aquatic macroinvertebrate diversity indexes in the Llobregat River (NE Spain). Environ. Int. 2010, 36(2):153-162.
29. Gonzalez-Rey M., Bebianno M.J. Non-steroidal anti-inflammatory drug (NSAID) Ibuprofen distresses antioxidant defense system in mussel Mytilus galloprovincialis gills. Aquat. Toxicol. 2011, 105:264-269.
30. Gonzalez-Rey M., Bebianno M.J. Does non-steroidal anti-inflammatory (NSAID) Ibuprofen induces antioxidant stress and endocrine disruption in mussel Mytilus galloprovincialis?. Environ. Toxicol. Pharmacol. 2012, 33(2):361-371.
31. Gonzalez-Rey M., Bebianno M.J. Does selective serotonin reuptake inhibitor (SSRI) fluoxetine affect mussel Mytilus galloprovincialis?. Environ. Pollut. 2013, 174:200-209.
32. Greenwald R.A. Handbook of Methods for Oxygen Radical Research 1985, CRC, Press, Boca Raton, FL.
33. Gros M., Petrovic M., Barceló D. Development of a multi-residue analytical methodology based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for screening and trace level determination of pharmaceuticals in surface and wastewaters. Talanta 2006, 70(4):678-690.
34. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione-S-transferases-the first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974, 249:7130-7139.
35. Halling-Sørensen B., Nielsen S.N., Lanzky P.F., Ingerslev F., Lutzhoft H.C.H., Jorgensen S.E. Occurrence, fate and effects of pharmaceutical substances in the environment-a review. Chemosphere 1998, 36:357-394.
36. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol. Lett. 2002, 131:5-17.
37. Hernando M.D., Heath E., Petrovic M., Barceló D. Trace-level determination of pharmaceutical residues by LC-MS/MS in natural and treated waters. A pilot-survey study. Anal. Bioanal. Chem. 2006, 385:985-991.
38. Hilton M.J., Thomas K.V. Determination of selected human pharmaceutical compounds in effluent and surface water samples by high-performance liquid chromatography-electrospray tandem mass spectrometry. J. Chromatogr. A 2003, 1015:129-141.
39. Hinz B., Brune K. Antipyretic analgesics: nonsteroidal antiinflammatory drugs, selective COX-2 inhibitors, paracetamol and pyrazolinones. Handb. Exp. Pharmacol. 2006, 2(177):65-93.
40. Isoda H., Talorete T.P.N., Kimura M., Maekawa T., Inamori Y., Nakajima N., Seki H. Phytoestrogens genistein and daidzin enhance the acetylcholinesterase activity of the rat pheochromocytoma cell line PC12 by binding to the estrogen receptor. Cytotechnology 2002, 40(1-3):117-123.
41. Jux U., Baginski R.M., Arnold H.-G., Krönke M., Seng P.N. Detection of pharmaceutical contaminations of river, pond, and tap water from Cologne (Germany) and surroundings. Int. J. Hyg. Environ. Health 2002, 205(5):393-398.
42. Kosjek T., Heath E., Krbavcic A. Determination of non-steroidal anti-inflammatory drug (NSAIDs) residues in water samples. Environ. Int. 2005, 31(5):679-685.
43. Lee J., Ji K., Kho Y.L., Kim P., Choi K. Chronic exposure to diclofenac on two freshwater cladocerans and Japanese medaka. Ecotoxicol. Environ. Saf. 2011, 74:1216-1225.
44. Letzel M., Metzner G., Letzel T. Exposure assessment of the pharmaceutical diclofenac based on long-term measurements of the aquatic input. Environ. Int. 2009, 35:363-368.
45. Lindqvist N., Tuhkanen T., Kronberg L. Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters. Water Res. 2005, 39(11):2219-2228.
46. Marco-Urrea E., Pérez-Trujillo M., Cruz-Morató C., Caminal G., Vicent T. Degradation of the drug sodium diclofenac by Trametes versicolor pellets and identification of some intermediates by NMR. J. Hazard. Mater. 2010, 176:836-842.
47. Martín-Díaz L., Franzellitti S., Buratti S., Valbonesi P., Capuzzo A., Fabbri E. Effects of environmental concentrations of the antiepilectic drug carbamazepine on biomarkers and cAMP-mediated cell signaling in the mussel Mytilus galloprovincialis. Aquat. Toxicol. 2009, 94(3):177-185.
48. Matozzo V., Gagné F., Marin M.G., Ricciardi F., Blaise C. Vitellogenin as a biomarker of exposure to estrogenic compounds in aquatic invertebrates: a review. Environ. Int. 2008, 34:531-545.
49. Matozzo V., Tomei A., Marin M.G. Acetylcholinesterase as a biomarker of exposure to neurotoxic compounds in the clam Tapes philippinarum from the Lagoon of Venice. Mar. Environ. Res. 2005, 50:1686-1693.
50. McCord J.M., Fridovich I. Superoxide dismutase: an enzymatic function for erythrocuprein (hemocuprein). J. Biol. Chem. 1969, 244(22):6049-6055.
51. Mun'im A., Isoda H., Seki M., Negishi O., Ozawa T. Estrogenic and acetylcholinesterase-enhancement activity of a new from Crotalaria sessililflora. Cytotechnology 2004, 43:127-134.
52. Nassef M., Kim S.G., Seki M., Kang I.J., Shimasaki Y., Oshima Y., Hano T. In ovo nanoinjection of triclosan, diclofenac and carbamazepine affects embryonic development of medaka fish (Oryzias latipes). Chemosphere 2010, 79:966-973.
53. Nassef M., Matsumoto S., Seki M., Khalil F., Kang I.J., Oshima Y., Honjo T., Shimasaki Y. Acute effects of triclosan, diclofenac and carbamazepine on feeding performance of Japanese medaka fish (Oryzias latipes). Chemosphere 2010, 80:1095-1100.
54. Ng L.E., Halliwell B., Wong K.P. Nephrotoxic cell death by diclofenac and meloxicam. Biochem. Biophys. Res. Commun. 2008, 369(3):873-877.
55. Oaks J.L., Gilbert M., Virani M.Z., Watson R.T., Meteyer C.U., Rideout B.A., Shivaprasad H.L., Ahmed S., Chaudhry M.J.I., Arshad M., Mahmood S., Ali A., Khan A.A. Diclofenac residues as the cause of vulture decline in Pakistan. Nature 2004, 427:630-633.
56. Öllers S., Singer H.P., Fassler P., Muller S.R. Simultaneous quantification of neutral and acidic pharmaceuticals and pesticides at the low-ng/l level in surface and waste water. J. Chromatogr. A 2001, 911(2):225-234.
57. Ortiz-Zarragoitia M., Cajaraville M.P. Intersex and oocyte atresia in a mussel population from the Biosphere's Reserve of Urdaibai (Bay of Biscay). Ecotoxicol. Environ. Saf. 2010, 73(5):693-701.
58. Osada M., Nomura T. The levels of reproductive cycle prostaglandins associated with the reproductive cycle of the scallop, Patinopecten yessoensis. Prostaglandins 1990, 40(3):229-239.
59. Oviedo-Gómez D.G.C., Galar-Martínez M., García-Medina S., Razo-Estrada C., Gómez-Oliván L.M. Diclofenac-enriched artificial sediment induces oxidative stress in Hyalella azteca. Environ. Toxicol. Pharmacol. 2010, 29:39-43.
60. Pailler J.-Y., Krein A., Pfister L., Hoffmann L., Guignard C. Solid phase extraction coupled to liquid chromatography-tandem mass spectrometry analysis of sulfonamides, tetracyclines, analgesics and hormones in surface water and wastewater in Luxembourg. Sci. Total Environ. 2009, 407:4736-4743.
61. Parolini M., Binelli A., Provini A. Assessment of the potential cyto-genotoxicity of the nonsteroidal anti-inflammatory drug (NSAID) diclofenac on the zebra mussel (Dreissena polymorpha). Water Air Soil Pollut. 2010, 217(1-4):589-601.
62. Parolini M., Quinn B., Binelli A., Provini A. Cytotoxicity assessment of four pharmaceutical compounds on the zebra mussel (Dreissena polymorpha) haemocytes, gill and digestive gland primary cell cultures. Chemosphere 2011, 84(1):91-100.
63. Porte C., Janer G., Lorusso L.C., Ortiz-Zarragoitia M., Cajaraville M.P., Fossi M.C., Canesi L. Endocrine disruptors in marine organisms: approaches and perspectives. Comp. Biochem. Physiol. C: Pharmacol. Toxicol. Endocrinol. 2006, 143(3):303-315.
64. Praveen Rao P.N., Knaus E.E. Evolution of nonsteroidal anti-inflammatory cyclooxygenase (COX) inhibition and beyond drugs (NSAIDs). North 2008, 11(2):81-110.
65. Quinn B., Schmidt W., O'Rourke K., Hernan R. Effects of the pharmaceuticals gemfibrozil and diclofenac on biomarker expression in the zebra mussel (Dreissena polymorpha) and their comparison with standardised toxicity tests. Chemosphere 2011, 84(5):657-663.
66. Rabiet M., Togola A., Brissaud F., Seidel J.-L., Budzinski H., Elbaz-Poulichet F. Consequences of treated water recycling as regards pharmaceuticals and drugs in surface and ground waters of a medium-sized Mediterranean catchment. Environ. Sci. Technol. 2006, 40(17):5282-5288.
67. Ricciardi F., Binelli A., Provini A. Use of two biomarkers (CYP450 and acetylcholinesterase) in zebra mussel for the biomonitoring of Lake Maggiore (Northern Italy). Environ. Toxicol. Pharmacol. 2006, 63:406-412.
68. Rowley A.F., Vogan C.L., Taylor G.W., Clare A.S. Prostaglandins in non insectan invertebrates: recent insights and unsolved problems. J. Exp. Biol. 2005, 208:3-14.
69. Ruggeri B., Thoroughgood C.A. Prostaglandins in aquatic fauna: a comprehensive review. Mar. Ecol. Prog. Ser. 1985, 23:301-306.
70. Saini M., Taggart M.A., Knopp D., Upreti S., Swarup D., Das A., Gupta P.K., Niesser R., Prakash V., Mateo R., Cuthbert R.J. Detecting diclofenac in livestock carcasses in India with an ELISA: a tool to prevent widespread vulture poisoning. Environ. Pollut. 2012, 160(1):11-16.
71. Schmidt W., O'Rourke K., Hernan R., Quinn B. Effects of the pharmaceuticals gemfibrozil and diclofenac on the marine mussel (Mytilus sp.) and their comparison with standardized toxicity tests. Mar. Pollut. Bull. 2011, 62(7):1389-1395.
72. Schmidt W., Rainville L.-C., McEneff G., Sheehan D., Quinn B. A proteomic evaluation of the effects of the pharmaceuticals diclofenac and gemfibrozil on marine mussels (Mytilus spp.): evidence for chronic sublethal effects on stress-response proteins. Drug Test Anal. 2013, 10 pp.
73. Schwaiger J., Ferling H., Mallow U., Wintermayr H., Negele R.D. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part I: Histopathological alterations and bioaccumulation in rainbow trout. Aquat. Toxicol. 2004, 68(2):141-150.
74. Solé M., Shaw J.P., Frickers P.E., Weadman J.W., Hutchinson T.H. Effects on feeding rate and biomarker responses of marine mussels experimentally exposed to propranolol and acetaminophen. Anal. Bioanal. Chem. 2010, 396(2):649-656.
75. Stanton M.G. Colorimetric determination of inorganic phosphate in the presence of biological material and adenosine triphosphate. Anal. Biochem. 1968, 22:27-34.
76. Taggart M.A., Cuthbert R., Das D., Sashikumar C., Pain D.J., Green R.E., Feltrer Y., Shultz S., Cunningham A.A., Meharg A.A. Diclofenac disposition in Indian cow and goat with reference to Gyps vulture population declines. Environ. Pollut. 2007, 147:60-65.
77. Taggart M.A., Senacha K.R., Green R.E., Jhala Y.V., Raghavan B., Rahmani A., Cuthbert R., Pain D.J., Meharg A.A.R. Diclofenac residues in carcasses of domestic ungulates available to vultures in India. Environ. Int. 2007, 33:759-765.
78. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998, 32(11):3245-3260.
79. Thomas K.V., Hilton M.J. The occurrence of selected human pharmaceutical compounds in UK estuaries. Mar. Pollut. Bull. 2004, 49:436-444.
80. Tixier C., Singer H.P., Foellers S., Müller S.R. Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environ. Sci. Technol. 2003, 37(6):1061-1068.
81. Togola A., Budzinski H. Multi-residue analysis of pharmaceutical compounds in aqueous samples. J. Chromatogr. A 2008, 1177(1):150-158.
82. Tsuchiya K., Yamamuro Y., Sensui N. Influence of estrogen on acetylcholinesterase activity in primary cultures of cerebral cells from neonatal rats. Anim. Sci. J. 2004, 75:53-58.
83. Van der Oost R., Beyer J., Vermeulen N.P.E. Fish bioaccumulation and biomarkers in environmental risk assessment: a review. Environ. Toxicol. Pharmacol. 2003, 13:57-149.
84. Vane J.R., Bakhle Y.S., Botting R.M. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. 1998, 38:97-120.
85. Viarengo A., Canesi L., Garcia Martinez P., Peters L.D., Livingstone D.R. Pro-oxidant processes and antioxidant defence systems in the tissues of the Antarctic scallop (Adamussium colbecki) compared with the Mediterranean scallop (Pecten jacobaeus). Comp. Biochem. Physiol. B: Biochem. Mol. Biol. 1995, 111(1):119-126.
86. Vulliet E., Cren-Olivé C. Screening of pharmaceuticals and hormones at the regional scale, in surface and groundwaters intended to human consumption. Environ. Pollut. 2011, 159(10):2929-2934.
87. Weigel S., Kallenborn R., Huhnerfuss H. Simultaneous solid-phase extraction of acidic, neutral and basic pharmaceuticals from aqueous samples at ambient (neutral) pH and their determination by gas chromatography-mass spectrometry. J. Chromatogr. A 2004, 1023:183-195.
88. Zhang X.J., Yang L., Zhao Q., Caen J.P., He H.Y., Guo L.H., Alemany M., Zhang L.Y., Shi Y.F. Induction of acetylcholinesterase expression during apoptosis in various cell types. Cell. Death Differ. 2002, 9:790-800.
89. Zuccato E., Bagnati R., Fioretti F., Natangelo M., Calamari D., Fanelli R. Environmental loads and detection of pharmaceuticals in Italy. Pharmaceuticals in the Environment-Sources, Fate, Effects and Risks 2001, 19-27. Springer, Berlin. K. Kümmerer (Ed.).